Bárbara Adamo
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
- Oncology 49
- HER2/EGFR in Cancer Research 19
- Cancer Treatment and Pharmacology 18
- Colorectal Cancer Treatments and Studies 5
-
- Advanced Breast Cancer Therapies 31
- Lung Cancer Treatments and Mutations 9
- Co-authors
- Aleix Prat (47 shared papers)Charles M. Perou (9 shared papers)Patricia Galván (17 shared papers)Montserrat Muñoz-Mateu (24 shared papers)Lisa A. Carey (10 shared papers)Carey K. Anders (8 shared papers)Aranzazu Fernández-Martínez (7 shared papers)Estela Pineda (2 shared papers)
- Journals
- Annals of Oncology (27 papers)Journal of Clinical Oncology (14 papers)Cancer Research (10 papers)ESMO Open (5 papers)Clinical Cancer Research (4 papers)
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Bárbara Adamo
88 papers receiving 3.7k citations
Bárbara Adamo's Hit Papers
Peers
Comparison fields: 5 of 109
- Cancer Research 1.2k
- Oncology 1.4k
- Pulmonary and Respiratory Medicine 793
- Molecular Biology 1.5k
- Genetics 118
Countries citing papers authored by Bárbara Adamo
This map shows the geographic impact of Bárbara Adamo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bárbara Adamo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bárbara Adamo more than expected).
Fields of papers citing papers by Bárbara Adamo
This network shows the impact of papers produced by Bárbara Adamo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bárbara Adamo. The network helps show where Bárbara Adamo may publish in the future.
Co-authors
The 25 scholars most cited alongside Bárbara Adamo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical implications of the intrinsic molecular subtypes of breast cancer Hit paper breakdown → | 2015 | 778 |
| 2 | 2013 | 407 | |
| 3 | 2013 | 304 | |
| 4 | 2015 | 303 | |
| 5 | 2020 | 243 | |
| 6 | 2014 | 162 | |
| 7 | 2013 | 156 | |
| 8 | 2014 | 147 | |
| 9 | 2015 | 115 | |
| 10 | 2011 | 85 | |
| 11 | 2013 | 81 | |
| 12 | 2016 | 76 | |
| 13 | 2013 | 74 | |
| 14 | 2015 | 66 | |
| 15 | 2015 | 55 | |
| 16 | 2015 | 54 | |
| 17 | 2008 | 51 | |
| 18 | 2013 | 45 | |
| 19 | 2012 | 34 | |
| 20 | 2014 | 34 |
About Bárbara Adamo
Bárbara Adamo is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Molecular Biology, having authored 96 papers that have together received 3.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (31 papers), Advanced Breast Cancer Therapies (31 papers), HER2/EGFR in Cancer Research (19 papers), Cancer Treatment and Pharmacology (18 papers), BRCA gene mutations in cancer (9 papers), Lung Cancer Treatments and Mutations (9 papers), Fibroblast Growth Factor Research (7 papers) and Colorectal Cancer Treatments and Studies (5 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.4k citations), Pulmonary and Respiratory Medicine (793 citations), Molecular Biology (1.5k citations) and Genetics (118 citations). Bárbara Adamo has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Aleix Prat, Charles M. Perou, Patricia Galván, Montserrat Muñoz-Mateu, Lisa A. Carey, Carey K. Anders, Aranzazu Fernández-Martínez, Estela Pineda, Ana Arance and Margarita Viladot. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Cancer Research, ESMO Open and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.